{"lastModified":"2024-12-16T22:00:27","links":[{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacja.xsp?typ=int&nr=6524","rel":"web-description"},{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacjaTresc.xsp?key=DBECN9","rel":"web-body"},{"href":"https://api.sejm.gov.pl/sejm/term10/interpellations/6524/body","rel":"body"}],"num":6524,"receiptDate":"2024-11-21","term":10,"title":"Interpelacja w sprawie dostępności dla pacjentów chorujących na hemofilię A i B nowoczesnego leczenia podskórną profilaktyką krwawień oraz lekami dożylnymi o przedłużonym działaniu","answerDelayedDays":0,"from":["071","095","113","155","234","353","356","418"],"recipientDetails":[{"answerDelayedDays":0,"name":"minister zdrowia","sent":"2024-11-27"}],"replies":[{"attachments":[{"URL":"https://api.sejm.gov.pl/sejm/term10/interpellations/attachment/ATTDBZJUS/i06524-o1.pdf","lastModified":"2024-12-16T22:00:27","name":"i06524-o1.pdf"}],"from":"Podsekretarz stanu Marek Kos","key":"DBZJUS","lastModified":"2024-12-16T22:00:27","links":[{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacjaTresc.xsp?key=DBZJUS","rel":"web-body"},{"href":"https://api.sejm.gov.pl/sejm/term10/interpellations/6524/reply/DBZJUS/body","rel":"body"}],"onlyAttachment":true,"prolongation":false,"receiptDate":"2024-12-12"}],"sentDate":"2024-11-27","to":["minister zdrowia"]}